Norbert G. Riedel, Director at Jazz Pharmaceuticals plc (JAZZ), sold 10,178 shares at $152.32 ($1.6M) on 2022-08-08, disclosed to the SEC on 2022-08-09.
Seasonal sale ($1.6M) by Director — this insider has traded JAZZ in August in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $155.87 | 8,000 | $1.2M | 79.0% |
| 2 | $152.32 | 1,089 | $166K | 10.5% |
| 3 | $152.32 | 1,089 | $166K | 10.5% |
| Total | $155.11 avg | 10,178 | $1.6M | 100% |
| Filing → |
| APTX | BUY | 2021-12-08 | $223K | — | Filing → |
| JAZZ | SELL | 2021-08-10 | $386K | — | Filing → |
| JAZZ | SELL | 2020-08-10 | $234K | — | Filing → |